← Leaderboards
Shervin Assassi
University Of Texas Hlth Sci Ctr Houston
$2,337,912
Attributed
$4,571,322
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $953.2K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,571,322 · 6
By mechanism
R01$2,562,644 · 2
R61$779,734 · 1
K23$493,922 · 1
R33$388,525 · 1
R56$346,497 · 1
Top collaborators
- Tingting Weng Mills5 shared
- Minghua Wu4 shared
- Kirill V Larin3 shared
- Chandra Mohan3 shared
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Harry Karmouty-Quintana$5,963,368
- John Duffin Reveille$11,528,689
- Tingting Weng Mills$2,089,049
- Michael R Blackburn$13,626,157
- Xiaodong Zhou$2,238,266
Others in their field
Top investigators on “Systemic Scleroderma”
- Eugene W. St Clair · Duke University$24,182,181
- John Varga · University Of Illinois At Chicago$13,781,985
- Carol A Feghali-Bostwick · University Of Pittsburgh At Pittsburgh$11,771,501
- Judith A James · Oklahoma Medical Research Foundation$11,331,322
- Robert M Elashoff · John Wayne Cancer Institute$10,394,671
- Maria Trojanowska · Boston University Medical Campus$10,085,547
Research focus
Systemic SclerodermaFibrosisMorbidity - Disease RateSkinRheumatismSclerodermaTranscriptSamplingIndium-BleomycinDermalMouse ModelTechnologySkin FibrosisEffective TherapyOrganMortalityTissuesBaseLeadBleomycinLinkPathogenesisKnock-DownMediating
Grant awards (17)
Interferon Regulatory Factor 7 Links Interferon Pathway Activation to the Exaggerates Fibrotic Response in Systemic Sclerosis$319,352
R01 · FY2025 · AR · contact PI
Interferon Regulatory Factor 7 Links Interferon Pathway Activation to the Exaggerates Fibrotic Response in Systemic Sclerosis$321,060
R01 · FY2024 · AR · contact PI
Combined Optical Coherence Elastography and Tomography for Assessing Skin Involvement in Systemic Sclerosis$388,525
R33 · FY2023 · AR · contact PI
CFlm25 mediated alternative polyadenylation regulates fibrosis in systemic sclerosis$339,816
R01 · FY2023 · AR · contact PI
Interferon Regulatory Factor 7 Links Interferon Pathway Activation to the Exaggerates Fibrotic Response in Systemic Sclerosis$224,865
R01 · FY2023 · AR · contact PI
Combined Optical Coherence Elastography and Tomography for Assessing Skin Involvement in Systemic Sclerosis$380,943
R61 · FY2022 · AR · contact PI
CFlm25 mediated alternative polyadenylation regulates fibrosis in systemic sclerosis$336,418
R01 · FY2022 · AR · contact PI
Role of Interferon Regulatory Factor 7 in Systemic Sclerosis Pathogenesis$346,497
R56 · FY2021 · AR · contact PI
CFlm25 mediated alternative polyadenylation regulates fibrosis in systemic sclerosis$329,621
R01 · FY2021 · AR · contact PI
Combined Optical Coherence Elastography and Tomography for Assessing Skin Involvement in Systemic Sclerosis$398,791
R61 · FY2020 · AR · contact PI
CFlm25 mediated alternative polyadenylation regulates fibrosis in systemic sclerosis$339,816
R01 · FY2020 · AR · contact PI
CFlm25 mediated alternative polyadenylation regulates fibrosis in systemic sclerosis$351,696
R01 · FY2019 · AR · contact PI
Molecular Markers for Progression of Pulmonary Fibrosis in Systemic Sclerosis$123,428
K23 · FY2014 · AR · contact PI
Molecular Markers for Progression of Pulmonary Fibrosis in Systemic Sclerosis$604
K23 · FY2014 · AR · contact PI
Molecular Markers for Progression of Pulmonary Fibrosis in Systemic Sclerosis$123,318
K23 · FY2013 · AR · contact PI
Molecular Markers for Progression of Pulmonary Fibrosis in Systemic Sclerosis$123,318
K23 · FY2012 · AR · contact PI
Molecular Markers for Progression of Pulmonary Fibrosis in Systemic Sclerosis$123,254
K23 · FY2011 · AR · contact PI